Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy.
Clin Exp Rheumatol
; 39(3): 546-554, 2021.
Article
in En
| MEDLINE
| ID: mdl-32940216
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Arthritis, Rheumatoid
/
Virus Activation
/
Hepatitis B virus
/
Tumor Necrosis Factor Inhibitors
/
Hepatitis B
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Clin Exp Rheumatol
Year:
2021
Document type:
Article
Affiliation country:
Italy